- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Procter & Gamble Health Limited has announced a board meeting to discuss the financial results for the quarter ended December 31, 2024, and declared an interim dividend of ₹80 per equity share for the financial year 2024-25, totaling ₹13,280 cr. The company's revenue from operations reached ₹30,971 cr, reflecting stable year-over-year performance. Net profit for the period stood at ₹9,090 cr, an increase compared to the previous quarter. The announcement suggests a positive outlook for shareholders driven by solid financial performance and dividend distribution, which could enhance investor sentiment.